CAMBRIDGE, Mass. (AP) _ Momenta Pharmaceuticals Inc. (MNTA) on Friday reported a fourth-quarter loss of $8.2 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 10 cents. Losses, adjusted for restructuring costs, were 7 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 46 cents per share.
The biotechnology company posted revenue of $42.8 million in the period.
For the year, the company reported that its loss widened to $176.1 million, or $2.26 per share. Revenue was reported as $75.6 million.
Momenta shares have climbed 26 percent since the beginning of the year. The stock has fallen 15 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MNTA at https://www.zacks.com/ap/MNTA